Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

He, Zhuohao, Guo, Jing L, McBride, Jennifer D, Narasimhan, Sneha, Kim, Hyesung, Changolkar, Lakshmi, Zhang, Bin, Gathagan, Ronald J +9 more·2018·Nature Medicine

Cited by (656)

Items 201–300 of 656

  1. Invited Review – Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials
    Delphine Boche, James A. R. Nicoll · 2020 · Neuropathology and Applied Neurobiology
  2. Roles of microglia in Alzheimer’s disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention
    Kazuyuki Takata, Florent Ginhoux, Shun Shimohama · 2021 · Biochemical Pharmacology
  3. The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration
    Amanda Engstrom, Alicia C. Walker, Rohitha A. Moudgal, Dexter A. Myrick, Stephanie M. Kyle, Yu Bai, M. Jordan Rowley, David J. Katz · 2020 · Proceedings of the National Academy of Sciences
  4. Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
    Kunié Ando, Sarah Houben, Mégane Homa, Marie-Ange de Fisenne, Marie‐Claude Potier, Christophé Erneux, Jean‐Pierre Brion, Karelle Leroy · 2021 · Frontiers in Molecular Neuroscience
  5. Docosahexaenoic acid enhances hippocampal insulin sensitivity to promote cognitive function of aged rats on a high-fat diet
    Jiqu Xu, Ben Ni, Congcong Ma, Shuang Rong, Hui Yuan Gao, Li Zhang, Xiang Xia, Qingde Huang, Qianchun Deng, Fenghong Huang · 2022 · Journal of Advanced Research
  6. Mitophagy in Alzheimer's disease and other metabolic disorders: A focus on mitochondrial-targeted therapeutics
    Shadt Skawratananond, Daniel X. Xiong, Charlie Zhang, Sahil S. Tonk, Aljon Pinili, Brad Delacruz, Patrick Pham, Shane C. Smith, Rahul Navab, P. Hemachandra Reddy · 2025 · Ageing Research Reviews
  7. What is strain in neurodegenerative diseases?
    Ye Tian, Lanxia Meng, Zhentao Zhang · 2019 · Cellular and Molecular Life Sciences
  8. The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation
    Hyunju Lee, Hanwoong Woo, Ha-Eun Lee, Hyongjun Jeon, Ka‐Young Ryu, Jin Han Nam, Seong Gak Jeon, HyunHee Park, Ji-Soo Lee, Kyung‐Min Han et al. · 2020 · Free Radical Biology and Medicine
  9. Retromer regulates the lysosomal clearance of MAPT/tau
    Julian M. Carosi, Leanne K. Hein, Mark van den Hurk, Robert Adams, Bridget Milky, Sanjna Singh, Cédric Bardy, Donna Denton, Sharad Kumar, Timothy J. Sargeant · 2020 · Autophagy
  10. INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
    Iguchi, Akihiro, Takatori, Sho, Kimura, Shingo, Muneto, Hiroki, Wang, Kai, Etani, Hayato, Ito, Genta, Sato, Haruaki, Hori, Yukiko, Sasaki, Junko et al. · 2023 · iScience
  11. Epigenetic basis of Alzheimer disease
    Ángeles C. Tecalco-Cruz, Josué O. Ramírez‐Jarquín, María Elizbeth Álvarez-Sánchez, Jesús Zepeda–Cervantes · 2020 · World Journal of Biological Chemistry
  12. Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research
    Tiffany W. Todd, Naeyma N. Islam, Casey N. Cook, Thomas R. Caulfield, Leonard Petrucelli · 2024 · Neuron
  13. The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
    Jing Di, Ibrar Ahmed Siddique, Zizheng Li, Ghattas J. Malki, Simon Hornung, Suman Dutta, Ian Hurst, Ella Ishaaya, Austin Wang, Sally Tu et al. · 2021 · Alzheimer s Research & Therapy
  14. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease
    Wenhui Qu, Ling Li · 2021 · The Neuroscientist
  15. Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults
    Qi Liu, Chang Liu, Feifei Hu, Xuan Deng, Yumei Zhang · 2022 · Frontiers in Medicine
  16. Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming
    Dayuan Wang, Xiao Qin Gu, Xinyi Ma, Jun Chen, Qizhi Zhang, Zhihua Yu, Juan Li, Hu Meng, Xiaofang Tan, Yuyun Tang et al. · 2022 · Acta Pharmaceutica Sinica B
  17. Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease
    Meichen Yu, Shannon L. Risacher, Kwangsik T. Nho, Qiuting Wen, Adrian L. Oblak, Frederick W. Unverzagt, Liana G. Apostolova, Martin Rhys Farlow, Jared R. Brosch, David Glenn Clark et al. · 2024 · Cell Reports
  18. Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
    Feng Han, JiaQie Lee, Xi Chen, Jacob Ziontz, Tyler J. Ward, Susan M. Landau, Suzanne L. Baker, Theresa M. Harrison, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
  19. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
    Aiko Robert, Michael Schöll, Thomas Vogels · 2021 · International Journal of Molecular Sciences
  20. Alzheimer’s disease: From basic science to precision medicine approach
    Forloni, Gianluigi · 2020 · BMJ Neurology Open
  21. Impact of Curcumin on Traumatic Brain Injury and Involved Molecular Signaling Pathways
    Tahereh Farkhondeh, Saeed Samarghandian, Babak Roshanravan, Leila Peivasteh-Roudsari · 2019 · Recent Patents on Food Nutrition & Agriculture
  22. Pharmacological Modulators of Tau Aggregation and Spreading
    Antonio Dominguez‐Meijide, Eftychia Vasili, Tiago F. Outeiro · 2020 · Brain Sciences
  23. Alzheimer’s Disease (AD) Therapeutics—2: Beyond Amyloid—Re-Defining AD and Its Causality to Discover Effective Therapeutics
    Mullane, Kevin, Williams, Michael · 2018 · Biochemical Pharmacology
  24. Tau Filaments and the Development of Positron Emission Tomography Tracers
    Michel Goedert, Yoshiki Yamaguchi, Sushil K. Mishra, Makoto Higuchi, Naruhiko Sahara · 2018 · Frontiers in Neurology
  25. Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy
    Biao Cheng, Yang Li, Liang Ma, Zhuoyi Wang, Robert B. Petersen, Ling Zheng, Yuchen Chen, Kun Huang · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  26. Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
    Wang, Zhifu, Wang, Qi, Li, Shihua, Li, Xiao-Jiang, Yang, Weili, He, Dajian · 2023 · Frontiers in Aging Neuroscience
  27. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden
    Juan Lantero‐Rodriguez, Cécile Tissot, Anniina Snellman, Stijn Servaes, Andréa Lessa Benedet, Nesrine Rahmouni, Laia Montoliu‐Gaya, Joseph Therriault, Wagner Scheeren Brum, Jenna Stevenson et al. · 2023 · Alzheimer s & Dementia
  28. Advanced nano delivery system for stem cell therapy for Alzheimer's disease
    Yilong Pan, Long Li, Ning Cao, Jun Liao, Huiyue Chen, Meng Zhang · 2024 · Biomaterials
  29. Chlorogenic acid enhances autophagy by upregulating lysosomal function to protect against SH‑SY5Y cell injury induced by H2O2
    Lijuan Gao, Yuan Dai, Xiaoqiong Li, Shi Meng, Zhanqiong Zhong, Shijun Xu · 2021 · Experimental and Therapeutic Medicine
  30. Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates
    Rodrigo Morales, Javiera B Bravo-Alegria, Inés Moreno‐González, Claudia A. Duran-Aniotz, Nazaret Gamez, George A. Edwards, Claudio A. Soto · 2021 · Molecular Psychiatry
  31. Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease
    Pengxia Qin, Yingying Ran, Yujing Liu, Chao Wei, Xiaoyi Luan, Haoqian Niu, Jie Peng, Jie Sun, Jingde Wu · 2022 · Bioorganic Chemistry
  32. Alzheimer Disease Pathology and Neurodegeneration in Midlife Obesity: A Pilot Study
    Mahsa Dolatshahi, Paul K. Commean, Farzaneh Rahmani, Jingxia Liu, LaKisha Lloyd, Caitlyn Nguyen, Nancy Hantler, Maria J. Ly, Gary Z. Yu, Joseph E. Ippolito et al. · 2023 · Aging and Disease
  33. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease
    Lei Yu, Vladislav Petyuk, Shinya Tasaki, Patricia A. Boyle, Chris Gaiteri, Julie A. Schneider, Philip L. De Jager, David Alan Bennett · 2019 · JAMA Neurology
  34. Insight Into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer’s Disease Protofibril Core
    Cass Leonard, Christian Phillips, James McCarty · 2021 · Frontiers in Molecular Biosciences
  35. NLRP3 Inflammasome Mediates Neurodegeneration in Rats with Chronic Neuropathic Pain
    Changhe Ren, Milian Chen, Guo Mu, Suangchun Peng, Xiangbo Liu, Cehua Ou · 2021 · Shock
  36. Cryo-EM structures of τ filaments from human brain
    Michel Goedert · 2021 · Essays in Biochemistry
  37. p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD
    Gong, Ping, Chen, Yan-qing, Lin, Ai-hua, Zhang, Hai-bo, Zhang, Yan, Ye, Richard D., Yu, Yang · 2020 · Alzheimer's Research & Therapy
  38. A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
    Xinyi Zhao, Wen Zeng, Hong Wei Xu, Zihan Sun, Yingxin Hu, Beibei Peng, Jennifer D. McBride, Jiangtao Duan, Juan Deng, Bin Zhang et al. · 2023 · Science Translational Medicine
  39. Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)
    Jie Liu, Heleen M.M. van Beusekom, Xian‐Le Bu, Gong Chen, Paulo Henrique Rosado-de-Castro, Xiaochun Chen, Xiaowei Chen, Andrew N. Clarkson, Tracy D. Farr, YuHong Fu et al. · 2023 · Neuroprotection/Neuroprotection (Chichester, England. Print)
  40. TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges
    Emilia Zgórzyńska · 2024 · Molecular and Cellular Neuroscience
  41. Alzheimer’s disease seeded tau forms paired helical filaments yet lacks seeding potential
    Pu Duan, Aurelio James Dregni, Hong Wei Xu, Lakshmi N. Changolkar, Virginia M.‐Y. Lee, Edward B. Lee, Mei Hong · 2024 · Journal of Biological Chemistry
  42. Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy
    Eleanna Kara, Jordan D. Marks, Adriano Aguzzi · 2018 · Trends in Molecular Medicine
  43. The amyloid state of proteins: A boon or bane?
    Md Nadir Hassan, Faisal Nabi, Asra Nasir Khan, Murtaza Shabbir Hussain, Waseem Ahmad Siddiqui, Vladimir Nikolaevich Uversky, Rizwan Hasan Khan · 2022 · International Journal of Biological Macromolecules
  44. Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease
    Kazuyuki Takata, Hiroyuki Kimura, Daijiro Yanagisawa, Koki Harada, Kaneyasu Nishimura, Yoshihisa Kitamura, Shun Shimohama, Ikuo Tooyama · 2022 · Molecules
  45. Mouse models of Alzheimer's disease for preclinical research
    Naoto Watamura, Kaori Sato, Takaomi C. Saido · 2022 · Neurochemistry International
  46. Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
    Jamal B. Williams, Qing Cao, Wei Wang, Young‐Ho Lee, Luye Qin, Ping Zhong, Yong Ren, Kaijie Ma, Zhen Yan · 2023 · Nature Communications
  47. Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
    Singh, Rishabh, Rai, Sanskriti, Bharti, Prahalad Singh, Zehra, Sadaqa, Gorai, Priya Kumari, Modi, Gyan Prakash, Rani, Neerja, Dev, Kapil, Inampudi, Krishna Kishore, Y., Vishnu V. et al. · 2024 · BMC Medicine
  48. Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae
    Rother, Christine, Uhlmann, Ruth E., Müller, Stephan A., Schelle, Juliane, Skodras, Angelos, Obermüller, Ulrike, Häsler, Lisa M., Lambert, Marius, Baumann, Frank, Xu, Ying et al. · 2022 · Nature Communications
  49. Peripherally misfolded proteins exacerbate ischemic stroke-induced neuroinflammation and brain injury
    Yanying Liu, Kalpana Subedi, Aravind Baride, Svetlana Romanova, Eduardo Alberto Callegari, Christa C. Huber, Xuejun Wang, Hongmin Wang · 2021 · Journal of Neuroinflammation
  50. Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies
    Amy E. Easton, Marianne Lerbech Jensen, Congwei Wang, Peter Hagedorn, Yu-Wen Li, Michael R. Weed, Jere E. Meredith, Valerie L. Guss, Kelli M. Jones, Martin B. Gill et al. · 2022 · Molecular Therapy — Nucleic Acids
  51. Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease
    Daniel C. Shippy, Abigail H. Evered, Tyler Kent Ulland · 2024 · Immunological Reviews
  52. Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathway
    Nicholas Sweeney, Tae Yeon Kim, Cody T. Morrison, Liangping Li, Diana M. Acosta, Jiawen Liang, Nithin V. Datla, Julie A. Fitzgerald, Haoran Huang, Xianglan Liu et al. · 2024 · Acta Neuropathologica
  53. PET Imaging in Animal Models of Alzheimer’s Disease
    Baosheng Chen, Bernadette V. Marquez-Nostra, Erika Belitzky, Takuya Toyonaga, Jie Tong, Yiyun Henry Huang, Zhengxin Cai · 2022 · Frontiers in Neuroscience
  54. The polyphenol EGCG directly targets intracellular amyloid‐β aggregates and promotes their lysosomal degradation
    Christopher Secker, Angelika Motzny, Simona Kostova, Alexander Buntru, Lucas Helmecke, Laura Reus, Robert Steinfort, Lydia Brusendorf, Annett Boeddrich, Nancy Neuendorf et al. · 2023 · Journal of Neurochemistry
  55. Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice
    Medawar, Evelyn, Benway, Tiffanie A., Liu, Wenfei, Hanan, Taylor A., Haslehurst, Peter, James, Owain T., Yap, Kenrick, Muessig, Laurenz, Moroni, Fabia, Nahaboo Solim, Muzammil A. et al. · 2019 · EBioMedicine
  56. Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia
    Sukanta Jash, Sayani Banerjee, Shi‐Bin Cheng, Bin Wang, Chenxi Qiu, Asami Kondo, Jan Ernerudh, Xiao Zhen Zhou, Kun Ping Lu, Surendra Sharma · 2023 · Nature Communications
  57. Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models
    Sarah Fernandes, Jasmin S. Revanna, Joshua M. Pratt, Nicholas Hayes, Maria Carolina Marchetto, Fred H. Gage · 2024 · Frontiers in Neuroscience
  58. Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer’s disease
    Yifei Cai, Jean E. Kanyo, Rashaun S. Wilson, Shveta Bathla, Pablo Leal Cardozo, Лей Тонг, Shanshan Qin, Lukas A. Fuentes, Iguaracy Pinheiro‐de‐Sousa, Tram Huynh et al. · 2025 · Nature Aging
  59. Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
    Eleonora Del Prete, Maria Francesca Beatino, Nicole Campese, Linda Giampietri, Gabriele Siciliano, Roberto Ceravolo, Filippo Baldacci · 2020 · Journal of Personalized Medicine
  60. Hippocampal Connectivity with Retrosplenial Cortex is Linked to Neocortical Tau Accumulation and Memory Function
    Jacob Ziontz, Jenna N. Adams, Theresa M. Harrison, Suzanne L. Baker, William J. Jagust · 2021 · Journal of Neuroscience
  61. Fluorescence Depolarization Kinetics to Study the Conformational Preference, Structural Plasticity, Binding, and Assembly of Intrinsically Disordered Proteins
    Anupa Majumdar, Samrat Mukhopadhyay · 2018 · Methods in enzymology on CD-ROM/Methods in enzymology
  62. AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in alzheimer's disease mice
    Günaydin, Caner, Sondhi, Dolan, Kaminsky, Stephen M., Lephart, Hailey C., Leopold, Philip L., Hackett, Neil R., Khanna, Richie, Crystal, Ronald G. · 2024 · Molecular Therapy
  63. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric‐Aβ mediates pathology maturation
    Morgane Darricau, Changsong Dou, Rémi Kinet, Tao Zhu, Li Zhou, Xianglei Li, Aurélie Bedel, Stéphane Claverol, Caroline Tokarski, Taxiarchis Katsinelos et al. · 2023 · Alzheimer s & Dementia
  64. Synaptic vulnerability to amyloid-β and tau pathologies differentially disrupts emotional and memory neural circuits
    Maria Dolores Capilla-López, Ángel Deprada-Fernandez, Yuniesky Andrade‐Talavera, Irene Martínez‐Gallego, Heriberto Coatl-Cuaya, Paula Sotillo Sotillo, José Rodrı́guez-Álvarez, Antonio Rodríguez Moreno, Arnaldo Parra‐Damas, Carlos A. Saura · 2025 · Molecular Psychiatry
  65. Variants inPPP2R2BandIGF2BP3are associated with higher tau deposition
    Vijay K. Ramanan, Xuewei Wang, Scott A. Przybelski, Sheelakumari Raghavan, Michael G. Heckman, Anthony J. Batzler, Matthew Kosel, Timothy J. Hohman, David S. Knopman, Jonathan Graff‐Radford et al. · 2020 · Brain Communications
  66. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
    Shengnan Zhang, Yi Zhu, Jinxia Lu, Zhenying Liu, Amanda G. Lobato, Wen Zeng, Jiaqi Liu, Jiali Qiang, Shuyi Zeng, Yaoyang Zhang et al. · 2022 · eLife
  67. Implication of tau propagation on neurodegeneration in Alzheimer’s disease
    Daniel Lamontagne-Kam, Anosha Kiran Ulfat, Vincent Hervé, Tra-My Vu, Jonathan Brouillette · 2023 · Frontiers in Neuroscience
  68. APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APPNL-G-F cerebral organoid model of Alzheimer’s disease
    Hang Liu, Fan Mei, Rongrong Ye, Xinyu Han, Shudan Wang, Yan Ding, Yun Zhi, Keliang Pang, Wei Guo, Bai Lu · 2024 · Cell Research
  69. Human subiculo-fornico-mamillary system in Alzheimer’s disease: Tau seeding by the pillar of the fornix
    Brainbank Neuro-CEB Neuropathology Network, Manon Thierry, Susana Boluda, Benoı̂t Delatour, Serge Marty, Danielle Seilhean, Marie‐Claude Potier, Charles J. Duyckaerts · 2019 · Acta Neuropathologica
  70. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
    Ilie‐Cosmin Stancu, Mattia Ferraiolo, Dick Terwel, Ilse Dewachter · 2019 · Advances in experimental medicine and biology
  71. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation
    Koller, Emily J., Ibanez, Kristen R., Vo, Quan, McFarland, Karen N., Gonzalez De La Cruz, Elsa, Zobel, Lillian, Williams, Tristan, Xu, Guilian, Ryu, Daniel, Patel, Preya et al. · 2022 · Neuropathology and Applied Neurobiology
  72. Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer’s Disease with Higher Specificity
    Seyed Hani Hojjati, Farnia Feiz, Sindy Ozoria, Qolamreza Ray Razlighi, for the Alzheimer’s Disease Neuroimaging Initiative · 2021 · Journal of Alzheimer s Disease
  73. Molecular Insights into Cell Type-specific Roles in Alzheimer’s Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling
    Wenhui Qu, Peter Canoll, Gunnar Hargus · 2022 · Neuroscience
  74. Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer’s Disease
    Klaus Grossmann · 2022 · Biomedicines
  75. Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
    Suzanne Lam, Anne‐Sophie Hérard, Susana Boluda, Fanny Petit, Sabiha Eddarkaoui, Karine Cambon, The Brainbank Neuro-CEB Neuropathology Network, Franck Letournel, Marie‐Laure Martin‐Négrier, Maxime Faisant et al. · 2022 · Acta Neuropathologica Communications
  76. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging
    Corrina S. Fonseca, Suzanne L. Baker, Lindsey Dobyns, Mustafa Janabi, William J. Jagust, Theresa M. Harrison · 2024 · Alzheimer s & Dementia
  77. Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease
    Jury-Garfe, Nur, Redding-Ochoa, Javier, You, Yanwen, Martínez, Pablo, Karahan, Hande, Chimal-Juárez, Enrique, Johnson, Travis S., Zhang, Jie, Resnick, Susan, Kim, Jungsu et al. · 2024 · Acta Neuropathologica
  78. TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer’s disease
    Yiheng Zhao, Qian Guo, Jia Tian, Wei Liu, Xiaochuan Wang · 2024 · Ageing Research Reviews
  79. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
    Mohammed Alrouji, Mohammed S. Alshammari, Tasqeeruddin Syed, Anas Shamsi · 2025 · Antioxidants
  80. Whole-Brain Three-Dimensional Profiling Reveals Brain Region Specific Axon Vulnerability in 5xFAD Mouse Model
    Jianping Zhang, Ben Long, Anan Li, Qingtao Sun, Jiaojiao Tian, Ting Luo, Zhangheng Ding, Hui Gong, Xiangning Li · 2020 · Frontiers in Neuroanatomy
  81. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β
    Sarah Helena Nies, Hideyuki Takahashi, Charlotte S. Herber, Anita J Huttner, Alison Chase, Stephen M. Strittmatter · 2021 · Journal of Biological Chemistry
  82. Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts
    Raffaele Cacciaglia, Gemma Salvadó, José Luís Molinuevo, Mahnaz Shekari, Carles Falcón, Grégory Operto, Marc Suárez‐Calvet, Marta Milà‐Alomà, Arianna Sala, Elena Rodriguez‐Vieitez et al. · 2022 · Molecular Psychiatry
  83. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
    Shuai Zhao, Ziqi Fan, Xinyi Zhang, Zheyu Li, Ting Shen, Kaicheng Li, Yaping Yan, Yunfeng Yuan, Jiali Pu, Jun Tian et al. · 2022 · Neurotherapeutics
  84. Connections between ApoE, sleep, and Aβ and tau pathologies in Alzheimer’s disease
    Katherine R. Sadleir, Robert J. Vassar · 2023 · Journal of Clinical Investigation
  85. Synergistic Effect of Amyloid-β and Tau Disrupts Neural Circuits
    Timir Tripathi, Parismita Kalita · 2019 · ACS Chemical Neuroscience
  86. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons
    Oakley, Derek H., Klickstein, Naomi, Commins, Caitlin, Chung, Mirra, Dujardin, Simon, Bennett, Rachel E., Hyman, Bradley T., Frosch, Matthew P. · 2021 · The Journal of Neuroscience
  87. Zinc utilization by microglia in Alzheimer’s disease
    Daniel C. Shippy, Sophia F. Oliai, Tyler Kent Ulland · 2024 · Journal of Biological Chemistry
  88. Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies
    Szymon Kotarba, Marta Kozłowska, Małgorzata Scios, Kamil Saramowicz, Julia Barczuk, Zuzanna Granek, Natalia Siwecka, Wojciech Wiese, Michał Golberg, Grzegorz Galita et al. · 2024 · International Journal of Molecular Sciences
  89. Longitudinal predictive modeling of tau progression along the structural connectome
    Fan Yang, Samadrita Roy Chowdhury, Heidi I.L. Jacobs, Jorge Sepulcre, Van Jay Wedeen, Keith A. Johnson, Joyita Dutta · 2021 · NeuroImage
  90. Protein degradation-associated mechanisms that are affected in Alzheimer´s disease
    Ángeles C. Tecalco-Cruz, José Pedraza‐Chaverrí, Alfredo Briones‐Herrera, Eduardo Cruz-Ramos, Lilia López‐Cánovas, Jesús Zepeda–Cervantes · 2022 · Molecular and Cellular Biochemistry
  91. Synthesis and biological evaluation of thieno[3,2- c ]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
    Ning Yan, Xiaolong Shi, Long-Qian Tang, Defeng Wang, Xun Li, Chao Liu, Zhaopeng Liu · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
  92. Pathogenic Role of RAGE in Tau Transmission and Memory Deficits
    Youbin Kim, Hyejin Park, Youngwon Kim, Seohyun Kim, Jae‐Hoon Lee, Hanseul Yang, Seo Jin Kim, Cathena Meiling Li, Haneul Lee, Do-Hyeong Na et al. · 2022 · Biological Psychiatry
  93. Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer’s disease by network pharmacology and molecular docking
    Suet Cheung, Yuan Zhong, Lei Wu, Xiaomeng Jia, Mengqi He, Yongjian Ai, Qisen Jiao, Qionglin Liang · 2024 · Journal of Ethnopharmacology
  94. Early detection and personalized medicine: Future strategies against Alzheimer's disease
    Antonio Di Meco, Robert J. Vassar · 2020 · Progress in molecular biology and translational science
  95. Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer’s Disease Pathology
    Takeshi Kawarabayashi, Takumi Nakamura, Kaoru Sato, Yusuke Seino, Sadanobu Ichii, Naoko Nakahata, Masamitsu Takatama, David A. Westaway, Peter St George‐Hyslop, Mikio Shoji · 2022 · Journal of Alzheimer s Disease
  96. Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease
    Jang, Jaemyung, Yeo, Seungeun, Baek, Soonbong, Jung, Hyun Jin, Lee, Mi Suk, Choi, Seung Hee, Choe, Youngshik · 2023 · Acta Neuropathologica Communications
  97. Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice
    Victoria Gómez‐Murcia, Agathe Launay, Kévin Carvalho, Anaëlle Burgard, Céline Mériaux, Raphaëlle Caillierez, Sabiha Eddarkaoui, Devrim Kilinc, Dolores Siedlecki‐Wullich, Mélanie Besegher et al. · 2024 · Brain
  98. Attenuative Effects of Fluoxetine and Triticum aestivum against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity
    Karema Abu‐Elfotuh, Ghada M. Ragab, Ahmad Salahuddin, Lubna Jamil, Ekram Nemr Abd Al Haleem · 2021 · Molecules
  99. Controlled and Selective Photo-oxidation of Amyloid-β Fibrils by Oligomeric p -Phenylene Ethynylenes
    Adeline M. Fanni, Daniel Okoye, Florencia A. Monge, Julia Hammond, Fahimeh Maghsoodi, Tye D. Martin, Gabriella Brinkley, M. Lisa Phipps, Deborah G. Evans, Jennifer S. Martinez et al. · 2022 · ACS Applied Materials & Interfaces
  100. Impact of APOE genotype on prion-type propagation of tauopathy
    Tristan Williams, Alejandra Jolie Ruiz, Angelica Maria Ruiz, Quan Vo, Wangchen Tsering, Guilian M. Xu, Karen N. McFarland, Benoit I. Giasson, Patrick M. Sullivan, David Borchelt et al. · 2022 · Acta Neuropathologica Communications